Farmak has changed the name of Mometasone (active ingredient: mometasone furoate), a drug for treatment of skin allergies, to Moleskin. The medication is available in the form of cream and ointment.
This drug is well-known among dermatologists and patients with skin allergy. It was the first generic copy of the original mometasone furoate marketed in Ukraine. Since 2007 the number of people using this medication has been growing year after year (the drug enjoys substantial increase in the number of packs sold). Moleskin was tested at 10 dermatology centers across Ukraine. It’s the only generic drug which showed the full conformity of clinical effects to the original drug during studies.
USD 500,000 to be provided by the Company will be used for the development of KSE (Kyiv School of Economics) to improve education in Ukraine. The pharmaceutical company Farmak will provide KSE with monetary funds to equip the training rooms and areas of the new campus, as well as to develop existing and launch new majors, […]
The Shostka Children’s Hospital that has made available inpatient treatment of children diagnosed with COVID-19 since April 2021 has been provided with medical and diagnostic equipment purchased by the Zhebrivski Family Charitable Foundation. The operating COVID-19 treatment unit at the Shostka Hospital will make it possible to provide the qualitative ...
Farmak as a leader of the Ukrainian pharmaceutical market* has been included in the rating of TOP 200 largest Ukrainian companies in terms of tax payments for 2020 and has become the only representative of the pharmaceutical industry in this rating. At year-end 2020, the Company transferred UAH 712.1 million of taxes and fees to […]